Please wait
0001628171424B5EX-FILING FEESS-3S-3truetrue333-277640 0001628171 2024-08-07 2024-08-07 0001628171 1 2024-08-07 2024-08-07 0001628171 1 2024-08-07 2024-08-07 0001628171 2 2024-08-07 2024-08-07 iso4217:USD xbrli:pure
Exhibit 107
Calculation of Filing Fee Tables
Form
S-3
(Form Type)
Revolution Medicines, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
 
     
Security 
Type 
  
Security
Class
Title
  
Fee 
Calculation Rule 
  
Amount 
Registered 
  
Proposed 
Maximum 
Offering 
Price Per 
Unit 
  
Maximum 
Aggregate 
Offering 
Price 
  
Fee
Rate
  
Amount of
Registration
Fee
Newly Registered Securities
Fees to Be
Paid 
   Equity    Common Stock, $0.0001 par value per share    Rules 457(o) and (r)    (1)    (2)    $500,000,000    0.00014760    $73,800 (3) 
Fees 
Previously 
Paid 
  
0

  
0

  
0

  
0

  
0

  
0

   0     0
 
   Total Offering Amounts    
 
   $500,000,000    0.00014760     $73,800 (3) 
 
   Total Fees Previously Paid    
 
  
 
  
 
  
 
   Total Fee Offsets    
 
  
 
  
 
   $9,451 (4)(5) 
 
   Net Fee Due    
 
  
 
  
 
   $64,349
Table 2: Fee Offset Claims and Sources
 
 
  
Registrant
or Filer
Name
  
Form

or
Filing Type
  
File

Number
  
Initial
Filing
Date
  
Filing 
Date 
  
Fee Offset
Claimed
  
Security
Type
Associated
with Fee
Offset
Claimed
  
Security
Title
Associated
with Fee
Offset
Claimed
  
Unsold
Securities
Associated
with Fee
Offset
Claimed
  
Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed
  
Fee

Paid
with
Fee
Offset
Source
Rules 457(b) and
0-11(a)(2)
Fee Offset
Claims
  
0

Fee Offset
Sources
  
0

Rule 457(p)
Fee Offset
Claims
   Revolution Medicines, Inc.   
424(b)(5)
  
333-277640
   March 4, 2024   
 
   $9,451 (5)     Equity    Common Stock, $0.0001 par value per share       $64,031,140   
 
Fee  Offset
Sources 
   Revolution Medicines, Inc.   
424(b)(5)
  
333-277640
   March 4, 2024   
 
  
 
  
 
  
 
  
 
  
 
   $9,451 (5) 
(1)
Consists of shares of the registrant’s common stock, $0.0001 par value per share (the “Common Stock”), to be issued and sold from time to time pursuant to that certain Sales Agreement, dated as of August 7, 2024, by and between the registrant and TD Securities (USA) LLC.
(2)
The proposed maximum per security and aggregate offering prices will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder.

(3)
Represents payment of registration fees previously deferred for the Registration Statement on Form
S-3ASR
(Registration
No. 333-277640),
filed with the Securities and Exchange Commission on March 4, 2024.
(4)
Represents the total of the fee offsets claimed pursuant to Rule 457(p) under the Securities Act of 1933, as amended (the “Securities Act”) for the portion of registration fee previously paid with respect to unsold securities, as set forth in Table 2. The registrant has terminated the offering related to the unsold securities associated with the claimed offset.
(5)
The registrant previously registered shares of its Common Stock, having an aggregate offering price of up to $124,825,544 (the “Prior ATM”), offered by means of a 424(b)(5) prospectus supplement, dated March 4, 2024 (the “Prior ATM Prospectus Supplement”), pursuant to this Registration Statement on Form
S-3ASR
(Registration No. 333-277640), filed with the Securities and Exchange Commission on March 4, 2024.
 
In connection with the filing of the Prior ATM Prospectus Supplement, the registrant made a contemporaneous fee payment in the amount of $18,424.25 (inclusive of (a) $11,571.33 of total fee offsets and (b) $6,852.92 of net fee due). Effective as of August 7, 2024, the Prior ATM was terminated, and the offering of such unsold shares of Common Stock previously registered pursuant to the Prior ATM Prospectus Supplement was deemed terminated (the “Prior ATM Termination”).
 
As of the Prior ATM Termination, shares of Common Stock having an aggregate offering price of up to $64,031,140 remained unsold under the Prior ATM Prospectus Supplement. Pursuant to Rule 457(p) under the Securities Act, the registration fee of $9,451.00 that has already been paid and remains unused with respect to the unsold shares of Common Stock previously registered pursuant to the Prior ATM Prospectus Supplement is offset against the registration fee of $73,800.00 due for this offering. The remaining balance of the registration fee, $64,349.00, has been paid in connection with this offering.